THE HEMOSTASIS SYSTEM STATUS IN CHILDREN WITH METABOLIC SYNDROME
https://doi.org/10.20538/1682-0363-2015-5-100-105
Abstract
The aim of the research was to study the characteristic properties of hemostasia system of children suffer-ing from metabolic syndrome (MS) and exogenous obesity.
Material and methods, A total of 58 children and adolescents aged from 9 to 16 with different stages of obesity. The examined were divided into two groups – the main group including children with MS (n = 33) and the control group including patients with exogenous obesity but without any indications of (n = 25). The presence of obesity was stated according to the criteria described by L.V. Kozlova and her co-authors (2008). All the examined patients had a biochemical blood analysis that included component determination of hemostasia system. The component determination was to reflect all the links of blood coagulation, so the following indices were analysed – activated partial thromboplastin time (A-PPT), prothrombin time (PTT), prothrombin ratio, level of fibrinogen, thrombin time, international normalized ratio (INR) and thrombocyte aggregation with ristomycin.
Results. The children suffering from MS compared with the children without this syndrome had signifi-cantly higher level of prothrombin time, thrombocyte aggregation with ristomycin as well as INR. The index of thrombocyte aggregation with ristomycin in the main group was not only higher than in the con-trol group but also exceeded the reference value. The boys with MS had a notably higher index of throm-bocyte aggregation with ristomycin than the boys suffering fron obesity. The girls with MS had a higher INR factor than the group of girls with obesity.
Conclusions. The research showed that with children suffering from MS their hemostatic system gets involved in the pathological process. The discovered peculiarities show inclination to hyper-coagulation
About the Authors
N. A. Tsaregorodtsev
Tver State Medical University, Tver
Russian Federation
Tsaregorodtsev Nikolay A.
Russian Federation
Tsaregorodtsev Nikolay A.
O. V. Ivanova
Tver State Medical University, Tver
Russian Federation
Ivanova Olga V.
Russian Federation
Ivanova Olga V.
O. A. Dianov
Tver State Medical University, Tver
Russian Federation
Dianov Oleg A.
Russian Federation
Dianov Oleg A.
References
1. Roitberg G.E. (ed.) Metabolicheskij sindrom [Metabolic syndrome]. Moscow, MED-press-inform Publ., 2007. 224 p. (in Russian).
2. Dedov I.I., Mel'nichenko G.A. (ed.) Ozhirenie: jetiologija, patogenez, klinicheskie aspekty [Obesity: etiology, patho-genesis, clinical aspects]. Moscow, MIA Publ., 2006 (in Russian).
3. Bolotova N.V., Aver'yanov A.P., Labeznikova S.V., Drono-va Ye.G. Gormonal'no-metabolicheskie narusheniya i ikh korrektsiya u detey s ozhireniem [Hormonal and metabolic disorders and their correction in obese children]. Problemy endokrinologii – Problems of Endocrinology, 2003, vol. 49, no. 4, pp. 22–26 (in Russian).
4. Kozlova L.V. Metabolicheskiy sindrom u detey i podrostkov [The metabolic syndrome in children and adolescents]. Mos-cow, GEOTAR-Media Publ., 2008 (in Russian).
5. Trushkina I.V., Fillipov G.P., Leontiyeva I.V. Prognozirovanie razvitiya metabolicheskogo sindroma v podrostkovom vozraste [Forecasting the development of the metabolic syndrome in adolescence]. Pediatriya – Pediatria, 2010, vol. 89, no. 5, pp. 33–36 (in Russian).
6. Shcherbakova M.Yu., Sinitsyn P.A. Sovremennye vzglyady na diagnostiku, klassifikatsiyu, printsipy formirovaniya gruppy riska i podkhody k lecheniyu detey s metaboliches-kim sindromom [Modern views on the diagnosis, classifica-tion, principles of risk and approaches to the treatment of children with metabolic syndrome]. Pediatriya – Pediatria, 2009, vol. 89, no. 3, pp. 123–127 (in Russian).
7. Biryukova Ye.V., Markina N.V. Glyukofazh – nastoyashchee i budushchee v farmakoterapii metabolicheskogo sin-droma [Glucophage – present and future in the pharma-cotherapy of metabolic syndrome]. Effektivnaya farmakoter-apiya v endokrinologii – Effective Pharmacotherapy in Endocrinology, 2007, no. 3, pp. 12–17 (in Russian).
8. Juhan-Vague I., Alessi M.C. PAI-1, obesity, insulin resistance and risk of cardiovascular events. Thromb. Hae-most., 1997, no. 78, pp. 656–660.
9. Vetchinnikova V.N. Reologicheskie i morfologicheskie pokazateli krovi v otsenke tyazhesti techeniya i effektivnosti lecheniya bronkholegochnykh serdechno-sosudistykh zabolevaniy [Rheological and morphological parameters of blood in the assessment of severity and effectiveness of the treatment of bronchopulmonary cardiovascular disease]. Gematologiya i transfuziologiya – Hematology and Transfusiology, 2002, vol. 47, no. 5, pp. 29–32 (in Russian).
10. Panchenko Ye.P. Kakie iz pokazateley gemostaza mogut pomoch' vrachu? [Which factors of hemostasia system can help a doctors?]. Klinicheskaya Laboratornaya Diagnostika, 2001, no. 9, pp. 18 (in Russian).
11. Goloborodova I.V. Morfo-biokhimicheskie osobennosti trombotsitov u bol'nykh metabolicheskim sindromom. Avtoref. dis. kand. med. nauk [Morphological and biochemi-cal characteristics of platelets in patients with metabolic syndrome. Author. Diss. Cand. med. sci.]. Moscow, 2010. 25 p. (in Russian).
12. Fritsma G.A. Evaluation of Hemostasis. Hematology: Clini-cal Principles and Applications. Ed. B. Rodak. W.B. Phila-delphia, Saunders Company Publ., 2002. P. 719–753.
Review
For citations:
Tsaregorodtsev N.A., Ivanova O.V., Dianov O.A. THE HEMOSTASIS SYSTEM STATUS IN CHILDREN WITH METABOLIC SYNDROME. Bulletin of Siberian Medicine. 2015;14(5):100-105. (In Russ.) https://doi.org/10.20538/1682-0363-2015-5-100-105
Views:
1041
Email this article 